NCT01088360View on ClinicalTrials.gov

Safety Study of Abatacept to Treat Rheumatoid Arthritis (B)

Active, not recruitingOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

June 30, 2029

Study Completion Date

June 30, 2029

Conditions
Rheumatoid Arthritis
Sponsors
All Listed Sponsors
collaborator

National Data Bank for Rheumatic Diseases (NDB)

OTHER

lead

Bristol-Myers Squibb

INDUSTRY